Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nova Molecular Technologies, Inc.

Latest From Nova Molecular Technologies, Inc.

Neurotrophic Bioscience Inc.

Despite setbacks by neuroscience companies Cephalon Inc. and Regeneron Pharmaceuticals Inc., the hope that neurotrophic factors will provide relief for millions of sufferers of neurodegenerative diseases, by slowing the progression of the disease, is alive and kicking. Neurotrophic Biosciences hopes to succeed where others have not by taking an approach that will apply combinations of highly specific neurotrophic factors, many of them newly discovered, to the treatment of neurodegenerative diseases.


Nova Molecular Inc.

Nova Molecular hopes to match the right Alzheimer's patients with the right drugs using pharmacogenetics.

BioPharmaceutical Medical Device

Inventing the Pharmacogenomics Business

Applying genomics technologies to drugs on market or in clinical development holds great promise. Drug companies can revive tired products by finding new customers, redefine the market for approved compounds, and design more effective medications. But the real commercial possibilities have yet to be tested.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Miscellaneous